Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatry Advisor
Suicide mortality increased among adolescents and young adults across the Americas from 2000 to 2021. Rates varied by age, sex, and region, with widening disparities observed in population-level data.
Emergency Medicine June 23rd 2026
Psychiatrist.com
A single 25-mg dose of synthetic psilocybin with structured psychological support produced rapid, large-magnitude reductions in suicidal ideation through 12 weeks in 20 treatment-resistant adults with major depressive disorder, with two participants experiencing worsening ideation.
Psychiatry June 9th 2026
Adjunctive cognitive behavioral therapy reduced depressive symptoms and ideation scores versus treatment as usual in a 93-patient feasibility trial of esketamine for major depression with suicidal ideation.
Psychiatry May 27th 2026
Verywell Mind
Consumer-facing guidance from Verywell Mind highlights how depression in adults over 60 frequently manifests as somatic complaints, cognitive changes, and social withdrawal rather than overt mood symptoms.
Family Medicine/General Practice May 13th 2026
“Additional research is needed to determine whether the modest elevations in suicidal behavior observed during treatment are due to true medication effects or to persistence in the distress that prompted treatment initiation.” — Study authors, Biological Psychiatry Global Open Science
Neurology April 1st 2026
Archives of Psychiatric Nursing
“The lived experience of youth who identify as TGD cannot be ignored and the belief that all youth have the inherent right to mental health care — regardless of gender or gender-identity — is reaffirmed.”
Family Nursing March 19th 2026